Shares in Bayer hit an almost 7-year low on Thursday after a U.S. jury awarded $...
FRANKFURT - Shares in Bayer hit an almost 7-year low on Thursday after a U.S. jury awarded $80 million to a man claiming use of the group’s weed killer Roundup caused his cancer, with thousands of similar lawsuits looming.
German chemicals giant Bayer, which bought Roundup maker Monsanto last year for $63 billion, said it would appeal the verdict. The trial is only the second of more than 11,200 Roundup lawsuits set to go to trial in the United States. “Even if Monsanto/Bayer may win some cases, there is great uncertainty about the number of victories and defeats. That is why we expect Bayer to try to settle the remaining cases,” said Bryan Garnier analyst Jean-Jacques Le Fur.
Monsanto’s Roundup was the first to contain glyphosate, the world’s most widely used weed killer. But it is no longer patent-protected and many other versions are available.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialJury says Bayer, which bought Monsanto last year, must pay $81 million to a man who claimed the company's Roundup weed killer caused his non-Hodgkin's lymphoma
Read more »
U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits. The jury in San Francisco federal court said the company was liable for
Read more »
Jury says Bayer must pay $81 million to man who alleged Roundup caused his cancerA U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.
Read more »
U.S. jury says Bayer must pay $80 million to man in Roundup cancer trialJury awards $80 million to man who claimed Bayer's Roundup weed killer caused his non-Hodgkin's lymphoma
Read more »
Ten more Brazilian states' soy growers join Bayer patent disputeSoy producer associations in 10 Brazilian states have filed a legal petition to ...
Read more »
Bayer CEO says his team retains backing of supervisory board: reportBayer's management retains the backing of its supervisory board, its chief ...
Read more »
Bayer, J&J settle blood thinner Xarelto litigation for $775 millionBayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed.
Read more »
Bayer, J&J settle U.S. Xarelto litigation for $775 millionBayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsu...
Read more »
Man awarded $80M in lawsuit claiming Roundup causes cancerPlaintiff proves that Roundup's design was defective, it lacked sufficient cancer warnings. Monsanto developed glyphosate, an active ingredient in its weed killer, in the 1970s, and it is now sold in more than 160 countries and widely used in the US.
Read more »